Dengfeng Cheng

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Positron Emission Tomography

Small Cell Lung Cancer

Photodynamic Therapy

Top Venues

Molecular pharmaceutics

Contrast media & molecular imaging

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Kaibin Lin, Dai Shi, Ai Wang, Junbo Ge, Dengfeng Cheng, Yan Yan
Noninvasive Monitoring of Early Cardiac Fibrosis in Diabetic Mice by [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT Imaging. ACS omega 9 (15) (2024)
Tingting Yang, Dai Shi, Qingyu Lin, Hua Shen, Hui Tan, Yuxia Liu, Hongcheng Shi, Dengfeng Cheng
Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4. Molecular pharmaceutics 21 (5) (2024)
Wenxue Hui, Suyun Pu, Xinyan Gao, Yunze Wang, Xiaochuan Zha, Kezhi Ding, Xiaoyu Zhang, Dengfeng Cheng, Hongcheng Shi, Zonghua Luo
Evaluation of a Positron Emission Tomography Tracer Targeting Colony-Stimulating Factor 1 Receptor for Detecting Pulmonary Inflammation. Molecular pharmaceutics (2024)
Wenxue Hui, Suyun Pu, Xinyan Gao, Yunze Wang, Xiaochuan Zha, Kezhi Ding, Xiaoyu Zhang, Dengfeng Cheng, Hongcheng Shi, Zonghua Luo
Evaluation of a Positron Emission Tomography Tracer Targeting Colony-Stimulating Factor 1 Receptor for Detecting Pulmonary Inflammation. Molecular pharmaceutics 21 (8) (2024)
Kaibin Lin, Dai Shi, Ai Wang, Junbo Ge, Dengfeng Cheng, Yan Yan
Noninvasive Monitoring of Early Cardiac Fibrosis in Diabetic Mice by [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT Imaging. ACS omega 9 (15) (2024)
Tingting Yang, Dai Shi, Qingyu Lin, Hua Shen, Hui Tan, Yuxia Liu, Hongcheng Shi, Dengfeng Cheng
Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4. Molecular pharmaceutics 21 (5) (2024)
Tingting Yang, Dai Shi, Qingyu Lin, Hua Shen, Hui Tan, Yuxia Liu, Hongcheng Shi, Dengfeng Cheng
Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4. Molecular pharmaceutics (2024)
Kaibin Lin, Dai Shi, Ai Wang, Junbo Ge, Dengfeng Cheng, Yan Yan
Noninvasive Monitoring of Early Cardiac Fibrosis in Diabetic Mice by [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT Imaging. ACS omega 9 (15) (2024)
Dai Shi, Wenhui Fu, Hui Tan, Qingyu Lin, Hongcheng Shi, Dengfeng Cheng
Preclinical Evaluation of 99m Tc-MAG 3 -5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99m Tc-MAG 3 -5-F(ab') 2 . Molecular pharmaceutics 21 (1) (2023)
Hongyan Yin, Guobing Liu, Yan Hu, Jie Xiao, Wujian Mao, Jing Lv, Haojun Yu, Qingyu Lin, Dengfeng Cheng, Hongcheng Shi
Dynamic Total-Body PET/CT Imaging Reveals Kinetic Distribution of 68 Ga-DOTATATE in Normal Organs. Contrast media & molecular imaging 2023 (2023)
Dai Shi, Wenhui Fu, Hui Tan, Qingyu Lin, Hongcheng Shi, Dengfeng Cheng
Preclinical Evaluation of 99m Tc-MAG 3 -5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99m Tc-MAG 3 -5-F(ab') 2 . Molecular pharmaceutics 21 (1) (2023)
Zhan Si, Yuan Cheng, Zhan Xu, Dai Shi, Hongcheng Shi, Dengfeng Cheng
Exploration of 68 Ga-DOTA-MAL as a Versatile Vehicle for Facile Labeling of a Variety of Thiol-Containing Bioactive Molecules. ACS omega 8 (5) (2023)
Zhan Si, Yuan Cheng, Zhan Xu, Dai Shi, Hongcheng Shi, Dengfeng Cheng
Exploration of 68 Ga-DOTA-MAL as a Versatile Vehicle for Facile Labeling of a Variety of Thiol-Containing Bioactive Molecules. ACS omega 8 (5) (2023)
Dai Shi, Zhan Xu, Yuan Cheng, Qingyu Lin, Zhan Si, Wenhui Fu, Tingting Yang, Hongcheng Shi, Dengfeng Cheng
124 I-Labeled Immuno-PET Targeting hTREM2 for the Diagnosis of Gastric Carcinoma. Molecular pharmaceutics (2023)
Dai Shi, Wenhui Fu, Hui Tan, Qingyu Lin, Hongcheng Shi, Dengfeng Cheng
Preclinical Evaluation of 99m Tc-MAG 3 -5-Fab Targeting TREM2 in Lung Cancer Mouse Models: A Comparison with 99m Tc-MAG 3 -5-F(ab') 2 . Molecular pharmaceutics (2023)
Yuan Cheng, Dai Shi, Renjie Ye, Wenhui Fu, Pengcheng Ma, Zhan Si, Zhan Xu, Lixin Li, Qingyu Lin, Dengfeng Cheng
Noninvasive evaluation of PD-L1 expression in non-small cell lung cancer by immunoPET imaging using an acylating agent-modified antibody fragment. European journal of nuclear medicine and molecular imaging (2023)
Hongyan Yin, Guobing Liu, Yan Hu, Jie Xiao, Wujian Mao, Jing Lv, Haojun Yu, Qingyu Lin, Dengfeng Cheng, Hongcheng Shi
Dynamic Total-Body PET/CT Imaging Reveals Kinetic Distribution of 68 Ga-DOTATATE in Normal Organs. Contrast media & molecular imaging 2023 (2023)
Dengfeng Cheng, Hui Lu
Application of New Molecular Probes in the Diagnosis and Treatment of Malignant Tumors. Cancers 15 (19) (2023)
Hongyan Yin, Guobing Liu, Yan Hu, Jie Xiao, Wujian Mao, Jing Lv, Haojun Yu, Qingyu Lin, Dengfeng Cheng, Hongcheng Shi
Dynamic Total-Body PET/CT Imaging Reveals Kinetic Distribution of 68 Ga-DOTATATE in Normal Organs. Contrast media & molecular imaging 2023 (2023)
Zhequan Fu, Qingyu Lin, Zhan Xu, Wenhui Fu, Dai Shi, Yuan Cheng, Tingting Yang, Guobing Liu, Hongcheng Shi, Dengfeng Cheng
Longitudinal Positron Emission Tomography Imaging with P2X7 Receptor-Specific Radioligand 18 F-FTTM in a Kainic Acid Rat Model of Temporal Lobe Epilepsy. ACS chemical neuroscience 13 (23) (2022)
Zhequan Fu, Qingyu Lin, Zhan Xu, Yanzhao Zhao, Yuan Cheng, Dai Shi, Wenhui Fu, Tingting Yang, Hongcheng Shi, Dengfeng Cheng
P2X7 receptor-specific radioligand 18 F-FTTM for atherosclerotic plaque PET imaging. European journal of nuclear medicine and molecular imaging 49 (8) (2022)
Dai Shi, Zhan Si, Zhan Xu, Yuan Cheng, Qingyu Lin, Zhequan Fu, Wenhui Fu, Tingting Yang, Hongcheng Shi, Dengfeng Cheng
Synthesis and Evaluation of 68 Ga-NOTA-COG1410 Targeting to TREM2 of TAMs as a Specific PET Probe for Digestive Tumor Diagnosis. Analytical chemistry 94 (9) (2022)
Dai Shi, Yiqiu Zhang, Zhan Xu, Zhan Si, Yuan Cheng, Dengfeng Cheng, Guobing Liu
Noninvasive Evaluation of EGFR Expression of Digestive Tumors Using 99m Tc-MAG 3 -Cet-F(ab') 2 -Based SPECT/CT Imaging. Molecular imaging 2022 (2022)
Yuan Cheng, Dai Shi, Zhan Xu, Zhihui Gao, Zhan Si, Yanzhao Zhao, Renjie Ye, Zhequan Fu, Wenhui Fu, Tingting Yang, Yan Xiu, Qingyu Lin, Dengfeng Cheng
124 I-Labeled Monoclonal Antibody and Fragment for the Noninvasive Evaluation of Tumor PD-L1 Expression In Vivo . Molecular pharmaceutics 19 (10) (2022)
Hui Tan, Mieradilijiang Abudupataer, Lin Qiu, Wujian Mao, Jie Xiao, Dengfeng Cheng, Hongcheng Shi
99m Tc-labeled Duramycin for detecting and monitoring cardiomyocyte death and assessing atorvastatin cardioprotection in acute myocardial infarction. Chemical biology & drug design 97 (2) (2020)
Lin Qiu, Wujian Mao, Hongyan Yin, Hui Tan, Dengfeng Cheng, Hongcheng Shi
Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels-Alder Reaction and Key Factors in the Pretargeted Synthetic Design. Contrast media & molecular imaging 2019 (2019)
Yiqiu Zhang, Lanfang Meng, Beilei Li, Hui Tan, Qing-Yu Lin, Dengfeng Cheng, Hongcheng Shi
Preliminary application of micro-SPECT/CT imaging by 99m Tc-tricine-EDDA-HYNIC-c-Met for non-small-cell lung cancer. Chemical biology & drug design 93 (4) (2018)